Reports for MINT PHARMACEUTICALS INC
Company Name
MINT PHARMACEUTICALS INC
Shortage reports
Actual shortage:
18 (13%)
Anticipated shortage:
0 (0%)
Avoided shortage:
1 (1%)
Resolved:
121 (86%)
140
Discontinuation Reports
To be discontinued:
0 (0%)
Discontinued:
29 (100%)
Reversed:
0 (0%)
29
34 (20%)
16 (89%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MINT-CITALOPRAM | 40MG | TABLET | Resolved | 2020-07-28 | 2024-12-05 | 121279 |
| MINT-CITALOPRAM | 40MG | TABLET | Resolved | 2020-04-27 | 2020-11-11 | 113285 |
| MINT-CITALOPRAM | 20MG | TABLET | Resolved | 2021-01-11 | 2021-06-22 | 131327 |
| MINT-CITALOPRAM | 20MG | TABLET | Resolved | 2020-08-19 | 2020-11-11 | 122507 |
| MINT-CITALOPRAM | 20MG | TABLET | Resolved | 2020-04-27 | 2020-10-10 | 113281 |
| MINT-CITALOPRAM | 20MG | TABLET | Resolved | 2020-07-28 | 2024-12-03 | 121276 |
| MINT-CLOPIDOGREL | 75MG | TABLET | Avoided shortage | 2018-04-06 | 2024-12-05 | 45117 |
| MINT-CLOPIDOGREL | 75MG | TABLET | Resolved | 2018-03-09 | 2024-12-05 | 42370 |
| MINT-DICLOFENAC | 0.1% | SOLUTION | Actual shortage | 2023-03-27 | 2025-03-03 | 188045 |
| MINT-DICLOFENAC | 0.1% | SOLUTION | Actual shortage | 2023-03-27 | 2025-03-03 | 188042 |
| MINT-DORZOLAMIDE/TIMOLOL | 5MG 20MG | SOLUTION | Resolved | 2018-01-11 | 2018-09-19 | 35753 |
| MINT-DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Resolved | 2018-04-12 | 2018-05-08 | 45536 |
| MINT-DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Resolved | 2023-07-24 | 2024-01-09 | 199939 |
| MINT-DULOXETINE | 60MG | CAPSULE (DELAYED RELEASE) | Resolved | 2018-04-12 | 2018-05-08 | 45539 |
| MINT-DUTASTERIDE | 0.5MG | CAPSULE | Resolved | 2018-01-04 | 2018-02-23 | 34914 |
| MINT-ESCITALOPRAM | 10MG | TABLET | Resolved | 2019-12-09 | 2020-06-09 | 100582 |
| MINT-ESCITALOPRAM | 20MG | TABLET | Resolved | 2019-12-09 | 2020-06-09 | 100585 |
| MINT-EZETIMIBE | 10MG | TABLET | Resolved | 2017-10-26 | 2017-11-11 | 27176 |
| MINT-FLUOXETINE | 10MG | CAPSULE | Resolved | 2018-07-31 | 2021-01-11 | 57064 |
| MINT-FLUOXETINE | 20MG | CAPSULE | Resolved | 2018-07-31 | 2021-01-11 | 57069 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MINT-CITALOPRAM | 40MG | TABLET | Discontinued | 2023-05-02 | 2023-05-03 | 191442 |
| MINT-CITALOPRAM | 20MG | TABLET | Discontinued | 2023-05-02 | 2023-05-03 | 191439 |
| MINT-CLOPIDOGREL | Discontinued | 2019-02-04 | 2019-02-05 | 74442 | ||
| MINT-CLOPIDOGREL | Discontinued | 2019-02-04 | 2019-02-05 | 74435 | ||
| MINT-CLOPIDOGREL | 75MG | TABLET | Discontinued | 2018-08-16 | 2018-08-17 | 58286 |
| MINT-CLOPIDOGREL | 75MG | TABLET | Discontinued | 2018-08-16 | 2018-08-17 | 58283 |
| MINT-DORZOLAMIDE/TIMOLOL | 5MG 20MG | SOLUTION | Discontinued | 2019-06-04 | 2019-06-04 | 85525 |
| MINT-FENOFIBRATE E | 145MG | TABLET | Discontinued | 2020-04-25 | 2020-04-25 | 113175 |
| MINT-IRBESARTAN/HCTZ | 12.5MG 300MG | TABLET | Discontinued | 2021-08-11 | 2021-08-11 | 143952 |
| MINT-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2021-08-11 | 2021-08-11 | 143956 |
| MINT-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2021-08-11 | 2021-08-11 | 143959 |
| MINT-LEVOFLOXACIN | 750MG | TABLET | Discontinued | 2022-10-02 | 2022-10-03 | 170859 |
| MINT-LEVOFLOXACIN | 500MG | TABLET | Discontinued | 2022-10-02 | 2022-10-03 | 170856 |
| MINT-LEVOFLOXACIN | 250MG | TABLET | Discontinued | 2022-10-02 | 2022-10-03 | 170853 |
| MINT-METFORMIN | 500MG | TABLET | Discontinued | 2019-07-04 | 2019-07-05 | 88513 |
| MINT-METFORMIN | 850MG | TABLET | Discontinued | 2020-03-09 | 2020-03-10 | 108292 |
| MINT-RIVASTIGMINE | 4.5MG | CAPSULE | Discontinued | 2017-06-21 | 2017-07-01 | 13565 |
| MINT-RIVASTIGMINE | 1.5MG | CAPSULE | Discontinued | 2017-06-21 | 2017-07-01 | 13562 |
| MINT-RIVASTIGMINE | 6MG | CAPSULE | Discontinued | 2017-06-21 | 2017-07-01 | 13559 |
| MINT-RIVASTIGMINE | 3MG | CAPSULE | Discontinued | 2017-06-21 | 2017-07-01 | 13556 |